Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs
Lisanne E. N. Manson, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Elisa J. F. Houwink, Arne Risselada, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan J. Touw, Roos van Westrhenen, Vera H.M. Deneer, Henk‐Jan Guchelaar
Topics & Concepts
OxcarbazepineCarbamazepinePharmacogeneticsLamotriginePhenytoinMedicinePharmacologyCYP2C9GenotypingTherapeutic drug monitoringEpilepsyDrugInternal medicineGenotypeBiologyGeneticsPsychiatryMetabolismCytochrome P450GenePharmacogenetics and Drug MetabolismDrug-Induced Adverse ReactionsPharmacological Effects and Toxicity Studies